TransEnterix, Inc. a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, announced that...
Zynerba Pharmaceuticals announced that the results from the Phase III CONNECT-FX study of Zygel (cannabidiol gel synthetic) for the treatment of behavioral symptoms in children and adolescents with Fragile X syndrome (FXS) were published in the Journal of Neurodevelopmental Disorders
Fujifilm Sonocare has announced CE mark approval for its newest generation of point-of-care ultrasound the X-Porte ultrasound kiosk. X-Porte uses...
Gene Therapy Restores All Immune Cell Types in Infants with X-linked Severe Combined Immunodeficiency
This is a 12 month study investigating the effectiveness and safety of tofactinib in treating the signs and symptoms, improving physical function and preserving bone structure in patients with active psoriatic arthritis...
Delirium is a postoperative complication that occurs frequently in patients older than 65 years, and presages adverse outcomes.
The National Institute for Health and Care Excellence (NICE) has now recommended Crysvita (burosumab) from Kyowa Hakko Kirin within its...
This trial will compare tisagenlecleucel to standard of care in adult participants with relapsed or refractory (r/r) follicular lymphoma.
The FDA announced that the Mobilett Mira, a portable digital X-ray system from Siemens, has received 510(k) approval. The Mira�s...
Although previous studies have included early reexploration for bleeding as a risk factor in analyzing adverse outcomes after cardiac operations, reexploration for bleeding has not been systematically examined as...